Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)

Last updated: November 28, 2023
Sponsor: University Hospitals, Leicester
Overall Status: Active - Recruiting

Phase

N/A

Condition

Vascular Diseases

Treatment

Observation

Clinical Study ID

NCT04388943
14022
  • Ages 18-90
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This project will examine the diagnosis and prognosis of patients with cardiovascular disease in hospital in- and outpatients and compare their characteristics with normal controls from the community. The cardiovascular diseases studied include coronary artery disease, heart failure, heart attacks, valve disease, cardiac surgery, dysrhythmias, aneurysms, embolism, strokes, peripheral vascular disease and hypertension. Current methods for diagnosis and predicting outcome in patients are limited and may lack accuracy. This study will collect clinical details, and blood and urine samples from patients for analysis of proteins, chemicals and genetic biomarkers which will enable an examination of the pathological mechanisms involved in cardiovascular disease. The data will also be used to improve diagnosis and also improve prediction of outcome in patients (future clinical events such as death, further hospitalisation with cardiovascular disease and the effects of any therapy given to the patients). In this way, we can develop accurate ways of assessing a patient's condition and how it could be effectively managed. The study will last for 20 years.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All outpatients and inpatients with cardiovascular disease, of either gender
  • Aged 18-90 years old
  • Examples of conditions include: coronary artery disease, heart failure, heart attacks (myocardial infarction), valve disease, cardiac surgery, dysrhythmias (includingatrial fibrillation), aneurysms, embolism, strokes, peripheral vascular disease,hypertension (and its complications, such as left ventricular hypertrophy) or thosepresenting with chest pain
  • Healthy volunteers
  • Aged 18-90 years old
  • From the community without cardiovascular or other diseases

Exclusion

Exclusion Criteria:

  • Any patient who is unable to give consent
  • Any patient with non-cardiovascular comorbidity likely to cause death within 6 months
  • Patients know to be infected with HIV, Hepatitis B or any other agent posing aninfection risk from unfixed material

Study Design

Total Participants: 9500
Treatment Group(s): 1
Primary Treatment: Observation
Phase:
Study Start date:
June 17, 2010
Estimated Completion Date:
March 31, 2027

Connect with a study center

  • University Hospitals Leicester

    Leicester,
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.